Protective effects elicited by levosimendan against liver ischemia/reperfusion injury in anesthetized rats

Liver Transplantation

Volumn 20, Issue 3, 2014, Pages 361-375

  Grossini, Elena ^a,b   Pollesello, Piero ^a,b   Bellofatto, Kevin ^a,b   Sigaudo, Lorenzo ^a,b   Farruggio, Serena ^a,b   Origlia, Veronica ^a,b   Mombello, Cristina ^a,b   Mary, David A S G ^a,b   Valente, Guido ^a,b   Vacca, Giovanni ^a,b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Azienda Ospedaliera Universitaria Maggiore Della Carita   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 9; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; LEVOSIMENDAN; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL X; PROTEIN KINASE B; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER BIOPSY; LIVER ISCHEMIA; LIVER PROTECTION; LIVER SURGERY; LIVER TRANSPLANTATION; MALE; NICK END LABELING; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PORTAL VEIN BLOOD FLOW; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

ANESTHESIA; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIOPSY; BLOOD FLOW VELOCITY; CASPASE 3; CELL SURVIVAL; DECANOIC ACIDS; GLUTATHIONE; HYDRAZONES; HYDROXY ACIDS; LIVER; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PHOSPHODIESTERASE INHIBITORS; PORTAL VEIN; POTASSIUM CHANNELS; PYRIDAZINES; RATS; REPERFUSION INJURY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84896726810     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23799     Document Type: Article

References (52)

1. Fan C, Zwacka RM, Engelhardt JF,. Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med (Berl) 1999; 77: 577-592.
2. Serracino-Inglott F, Habib NA, Mathie RT,. Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181: 160-166.
3. Lemasters JJ, Thurman RG,. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 1997; 37: 327-338.
4. Pirenne J, Gunson B, Khaleef H, Hubscher S, Afford S, McMaster P, Adams D,. Influence of ischemia-reperfusion injury on rejection after liver transplantation. Transplant Proc 1997; 29: 366-367.
5. Howard TK, Klintmalm GB, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA,. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49: 103-107.
6. Zhai Y, Busuttil RW, Kupiec-Weglinski JW,. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant 2011; 11: 1563-1569.
7. Li JQ, Qi HZ, He ZJ, Hu W, Si ZZ, Li YN, Li DB,. Cytoprotective effects of human interleukin-10 gene transfer against necrosis and apoptosis induced by hepatic cold ischemia/reperfusion injury. J Surg Res 2009; 157: e71-e78.
8. Gao W, Bentley RC, Madden JF, Clavien PA,. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998; 27: 1652-1660.
9. Wang Y, Schattenberg JM, Rigoli RM, Storz P, Czaja MJ,. Hepatocyte resistance to oxidative stress is dependent on protein kinase C-mediated down-regulation of c-Jun/AP-1. J Biol Chem 2004; 279: 31089-31097.
10. Carini R, Grazia De Cesaris M, Splendore R, Baldanzi G, Nitti MP, Alchera E, et al. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 2004; 127: 914-923.
11. Koh PO,. Melatonin prevents hepatic injury-induced decrease in Akt downstream targets phosphorylations. J Pineal Res 2011; 51: 214-219.
12. Guo JY, Yang T, Sun XG, Zhou NY, Li FS, Long D, et al. Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway. J Biomed Sci 2011; 18: 79.
13. 2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. J Biol Chem 1994; 269: 28584-28590.
14. Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Lindén IB,. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 1995; 25: 794-801.
15. Haikala H, Pollesello P,. Calcium sensitivity enhancers. IDrugs 2000; 3: 1199-1205.
16. Kaheinen P, Pollesello P, Levijoki J, Haikala H,. Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels. J Cardiovasc Pharmacol 2001; 37: 367-374.
17. Grossini E, Caimmi PP, Molinari C, Teodori G, Vacca G,. Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig. J Cardiovasc Pharmacol 2005; 46: 333-342.
18. Grossini E, Molinari C, Caimmi PP, Uberti F, Vacca G,. Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel. Br J Pharm 2009; 156: 250-261.
19. +-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine. Eur J Heart Fail 2005; 7: 882-887.
20. Parissis JT, Andreadou I, Markantonis SL, Bistola V, Louka A, Pyriochou A, et al. Effects of levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure. Atherosclerosis 2007; 195: e210-e215.
21. De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ,. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007; 104: 766-773.
22. Caimmi PP, Molinari C, Uberti F, Micalizzi E, Valente G, Mary DA, et al. Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide. Eur J Cardiothorac Surg 2011; 39: e59-e67.
23. Uberti F, Caimmi PP, Molinari C, Mary D, Vacca G, Grossini E,. Levosimendan modulates programmed forms of cell death through K(ATP) channels and nitric oxide. J Cardiovasc Pharmacol 2011; 57: 246-258.
24. Grossini E, Caimmi PP, Platini F, Molinari C, Uberti F, Cattaneo M, et al. Modulation of programmed forms of cell death by intracoronary levosimendan during regional myocardial ischemia in anesthetized pigs. Cardiovasc Drugs Ther 2010; 24: 5-15.
25. Grossini E, Molinari C, Pollesello P, Bellomo G, Valente G, Mary D, et al. Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs. J Pharmacol Exp Ther 2012; 342: 376-388.
26. Yun N, Kang JW, Lee SM,. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. J Nutr Biochem 2012; 23: 1249-1255.
27. Chattopadhyay P, Shukla G, Wahi AK,. Protective effect of l -arginine against necrosis and apoptosis induced by experimental ischemic and reperfusion in rat liver. Saudi J Gastroenterol 2009; 15: 156-162.
28. Suzuki S, Nakamura S, Koizumi T, Sakaguchi S, Baba S, Muro H, Fujise Y,. The beneficial effect of a prostaglandin I2 analog on ischemic rat liver. Transplantation 1991; 52: 979-983.
29. Lee LY, Kaizu T, Toyokawa H, Zhang M, Ross M, Stolz DB, et al. Carbon monoxide induces hypothermia tolerance in Kupffer cells and attenuates liver ischemia/reperfusion injury in rats. Liver Transpl 2011; 17: 1457-1466.
30. Duenschede F, Erbes K, Riegler N, Ewald P, Kircher A, Westermann S, et al. Protective effects of ischemic preconditioning and application of lipoic acid prior to 90 min of hepatic ischemia in a rat model. World J Gastroenterol 2007; 13: 3692-3698.
31. Mueller TH, Kienle K, Beham A, Geissler EK, Jauch KW, Rentsch M,. Caspase 3 inhibition improves survival and reduces early graft injury after ischemia and reperfusion in rat liver transplantation. Transplantation 2004; 78: 1267-1273.
32. Duranski MR, Elrod JW, Calvert JW, Bryan NS, Feelisch M, Lefer DJ,. Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 291: H2980-H2986.
33. Peralta C, Prats N, Xaus C, Gelpí E, Rosellõ-Catafau J,. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 1999; 30: 1481-1489.
34. Datta G, Fuller BJ, Davidson BR,. Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol 2013; 19: 1683-1698.
35. Sato T, Marbán E,. The role of mitochondrial K(ATP) channels in cardioprotection. Basic Res Cardiol 2000; 95: 285-289.
36. Köken T, Inal M,. The effect of nitric oxide on ischemia-reperfusion injury in rat liver. Clin Chim Acta 1999; 288: 55-62.
37. Ben Mosbah I, Alfany-Fernández I, Martel C, Zaouali MA, Bintanel-Morcillo M, Rimola A, et al. Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis 2010; 1: e52.
38. Liu X, Kim CN, Yang J, Jemmerson R, Wang X,. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 1996; 86: 147-157.
39. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S,. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.
40. Cursio R, Gugenheim J, Ricci JE, Crenesse D, Rostagno P, Maulon L, et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 1999; 13: 253-261.
41. Kim K, Jung N, Lee K, Choi J, Kim S, Jun J, et al. Dietary omega-3 polyunsaturated fatty acids attenuate hepatic ischemia/reperfusion injury in rats by modulating toll-like receptor recruitment into lipid rafts. Clin Nutr 2013; 32: 855-862.
42. Satake A, Takaoka M, Nishikawa M, Yuba M, Shibata Y, Okumura K, et al. Protective effect of 17β-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway. Kidney Int 2008; 73: 308-317.
43. Fang SJ, Wu XS, Han ZH, Zhang XX, Wang CM, Li XY, et al. Neuregulin-1 preconditioning protects the heart against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Chin Med J (Engl) 2010; 123: 3597-3604.
44. Noma A,. ATP-regulated K+ channels in cardiac muscle. Nature 1983; 305: 147-148.
45. Bajgar R, Seetharaman S, Kowaltowski AJ, Garlid KD, Paucek P,. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem 2001; 276: 33369-33374.
46. Debska G, Kicinska A, Skalska J, Szewczyk A, May R, Elger CE, Kunz WS,. Opening of potassium channels modulates mitochondrial function in rat skeletal muscle. Biochim Biophys Acta 2002; 1556: 97-105.
47. Inoue I, Nagase H, Kishi K, Higuti T,. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 1991; 352: 244-247.
48. Ferranti R, da Silva MM, Kowaltowski AJ,. Mitochondrial ATP-sensitive K+ channel opening decreases reactive oxygen species generation. FEBS Lett 2003; 536: 51-55.
49. Zeng Z, Huang HF, He F, Wu LX, Lin J, Chen MQ,. Diazoxide attenuates ischemia/reperfusion injury via upregulation of heme oxygenase-1 after liver transplantation in rats. World J Gastroenterol 2012; 18: 1765-1772.
50. Onody P, Stangl R, Fulop A, Rosero O, Garbaisz D, Turoczi Z, et al. Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury? PLoS One 2013; 8: e73758.
51. Clavien PA, Harvey PR, Strasberg SM,. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992; 53: 957-978.
52. Ke B, Lipshutz GS, Kupiec-Weglinski JW,. Gene therapy in liver ischemia and reperfusion injury. Curr Pharm Des 2006; 12: 2969-2975.